Missing/wrong data?
Log in to edit
C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.
scientific article published in January 2004
Author/s
author: John M. Lachin, Kevan C Herold, Carla J Greenbaum, Jay S Skyler, Jerry P. Palmer
Work details
Publication date
January 1, 2004
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.